Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13D

Bi-allelic null mutations affecting UNC13D, STXBP2, or STX11 result in defects of lymphocyte cytotoxic degranulation and commonly cause familial hemophagocytic lymphohistiocytosis (FHL) in early life. Patients with partial loss of function are increasingly being diagnosed after presenting with alter...

Full description

Bibliographic Details
Main Authors: Paul Edgar Gray, Bella Shadur, Susan Russell, Richard Mitchell, Michael Buckley, Kerri Gallagher, Ian Andrews, Kevin Thia, Joseph A. Trapani, Edwin Philip Kirk, Ilia Voskoboinik
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.00944/full
_version_ 1818304379650834432
author Paul Edgar Gray
Bella Shadur
Susan Russell
Richard Mitchell
Michael Buckley
Kerri Gallagher
Ian Andrews
Kevin Thia
Joseph A. Trapani
Edwin Philip Kirk
Ilia Voskoboinik
author_facet Paul Edgar Gray
Bella Shadur
Susan Russell
Richard Mitchell
Michael Buckley
Kerri Gallagher
Ian Andrews
Kevin Thia
Joseph A. Trapani
Edwin Philip Kirk
Ilia Voskoboinik
author_sort Paul Edgar Gray
collection DOAJ
description Bi-allelic null mutations affecting UNC13D, STXBP2, or STX11 result in defects of lymphocyte cytotoxic degranulation and commonly cause familial hemophagocytic lymphohistiocytosis (FHL) in early life. Patients with partial loss of function are increasingly being diagnosed after presenting with alternative features of this disease, or with HLH later in life. Here, we studied two sisters with lymphocyte degranulation defects secondary to compound heterozygote missense variants in UNC13D. The older sibling presented aged 11 with linear growth arrest and delayed puberty, 2 years prior to developing transient ischemic attacks secondary to neuroinflammation and hypogammaglobulinemia, but no FHL symptoms. Her geno-identical younger sister was initially asymptomatic but then presented at the same age with severe EBV-driven infectious mononucleosis, which was treated aggressively and did not progress to HLH. The sisters had similar natural killer cell degranulation; however, while cytotoxic activity was moderately reduced in the asymptomatic patient, it was completely absent in both siblings during active disease. Following allogeneic bone marrow transplantation at the age of 15, the older child has completely recovered NK cell cytotoxicity, is asymptomatic, and has experienced an exceptional compensatory growth spurt. Her younger sister was also successfully transplanted and is currently disease free. The current study reveals previously unappreciated manifestations of FHL in patients who inherited hypomorphic gene variants and also raises the important question of whether a threshold of minimum NK function can be defined that should protect a patient from serious disease manifestations such as HLH.
first_indexed 2024-12-13T06:09:46Z
format Article
id doaj.art-9b1fec07a2704ab881fd21c60040f714
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-13T06:09:46Z
publishDate 2017-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-9b1fec07a2704ab881fd21c60040f7142022-12-21T23:57:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-08-01810.3389/fimmu.2017.00944292033Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13DPaul Edgar Gray0Bella Shadur1Susan Russell2Richard Mitchell3Michael Buckley4Kerri Gallagher5Ian Andrews6Kevin Thia7Joseph A. Trapani8Edwin Philip Kirk9Ilia Voskoboinik10Department of Immunology and Infectious Diseases, Sydney Children’s Hospital, Randwick, NSW, AustraliaDepartment of Immunology and Infectious Diseases, Sydney Children’s Hospital, Randwick, NSW, AustraliaKids Cancer Centre, Sydney Children’s Hospital, Randwick, NSW, AustraliaKids Cancer Centre, Sydney Children’s Hospital, Randwick, NSW, AustraliaGenetics Laboratory, South Eastern Area Laboratory Services, Randwick, NSW, AustraliaDepartment of Immunology, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaDepartment of Neurology, Sydney Children’s Hospital, Randwick, NSW, AustraliaCancer Cell Death Laboratory, Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne VIC, AustraliaCancer Cell Death Laboratory, Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne VIC, AustraliaCentre for Clinical Genetics, Sydney Children’s Hospital, Randwick, NSW, AustraliaKiller Cell Biology Laboratory, Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, VIC, AustraliaBi-allelic null mutations affecting UNC13D, STXBP2, or STX11 result in defects of lymphocyte cytotoxic degranulation and commonly cause familial hemophagocytic lymphohistiocytosis (FHL) in early life. Patients with partial loss of function are increasingly being diagnosed after presenting with alternative features of this disease, or with HLH later in life. Here, we studied two sisters with lymphocyte degranulation defects secondary to compound heterozygote missense variants in UNC13D. The older sibling presented aged 11 with linear growth arrest and delayed puberty, 2 years prior to developing transient ischemic attacks secondary to neuroinflammation and hypogammaglobulinemia, but no FHL symptoms. Her geno-identical younger sister was initially asymptomatic but then presented at the same age with severe EBV-driven infectious mononucleosis, which was treated aggressively and did not progress to HLH. The sisters had similar natural killer cell degranulation; however, while cytotoxic activity was moderately reduced in the asymptomatic patient, it was completely absent in both siblings during active disease. Following allogeneic bone marrow transplantation at the age of 15, the older child has completely recovered NK cell cytotoxicity, is asymptomatic, and has experienced an exceptional compensatory growth spurt. Her younger sister was also successfully transplanted and is currently disease free. The current study reveals previously unappreciated manifestations of FHL in patients who inherited hypomorphic gene variants and also raises the important question of whether a threshold of minimum NK function can be defined that should protect a patient from serious disease manifestations such as HLH.http://journal.frontiersin.org/article/10.3389/fimmu.2017.00944/fullcytotoxic lymphocytesHLHimmunodeficiencyhematologypathology
spellingShingle Paul Edgar Gray
Bella Shadur
Susan Russell
Richard Mitchell
Michael Buckley
Kerri Gallagher
Ian Andrews
Kevin Thia
Joseph A. Trapani
Edwin Philip Kirk
Ilia Voskoboinik
Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13D
Frontiers in Immunology
cytotoxic lymphocytes
HLH
immunodeficiency
hematology
pathology
title Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13D
title_full Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13D
title_fullStr Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13D
title_full_unstemmed Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13D
title_short Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13D
title_sort late onset non hlh presentations of growth arrest inflammatory arachnoiditis and severe infectious mononucleosis in siblings with hypomorphic defects in unc13d
topic cytotoxic lymphocytes
HLH
immunodeficiency
hematology
pathology
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.00944/full
work_keys_str_mv AT pauledgargray lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT bellashadur lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT susanrussell lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT richardmitchell lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT michaelbuckley lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT kerrigallagher lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT ianandrews lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT kevinthia lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT josephatrapani lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT edwinphilipkirk lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d
AT iliavoskoboinik lateonsetnonhlhpresentationsofgrowtharrestinflammatoryarachnoiditisandsevereinfectiousmononucleosisinsiblingswithhypomorphicdefectsinunc13d